- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02943226
Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter
May 3, 2018 updated by: Joseph P Hasapes, The University of Texas Health Science Center, Houston
IV Contrast Administration: Effect of Three Side Hole Infusion Catheter on CT Image Quality, Infusion Pressure, and Infusion Rates, Compared to a Standard Infusion Catheter
The purpose of this research study is to compare two types of catheters used for infusing the contrast dye necessary for viewing internal organs during computed tomography (CT) scanning.
The standard catheter, which has one hole from which contrast dye enters veins, will be compared to the Becton Dickinson Nexiva Diffusics System catheter, which has three holes for diffusing dye into veins.
The purpose of this study is to determine which catheter type gives the best image.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This will be a prospective, randomized, controlled trial.
The catheter is already in use at our facilities.
After informed consent, patients will be randomly given the standard or new catheter in our practice.
Envelopes with the random assignment will be available to the individuals consenting patients.
Randomization generally ensures that study groups are similar on average.
As age, sex, and weight impact image quality, we will collect data on these factors in case randomization results in an imbalance.
This will allow for control of these factors in analysis of the data.
Data will be collected from CT abdomen pelvis examinations within a 6 month-1 year period in 2016 - 2017.
Our primary outcome is image quality, measured as tissue density and distribution of contrast within the liver, spleen, aorta and IVC.
Our secondary outcomes include Peak Contrast Infusion Pressure and Injection Flow Rate.
Possible adverse events for use of any type of catheter include contrast infiltration into the subcutaneous tissues which is a minor limited event.
All infiltrations will be recorded as part of the permanent medical record, documented in the chart, and the referring physician notified.
The patient will be assessed by a physician immediately and referred to the ED if necessary for further evaluation.
Current technology utilizes Power injector equipment which alerts the technologist to the pressure being achieved.
If the injection pressure exceeds 325 psi the Power injector automatically shuts off.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing contrast enhanced CT abdomen pelvis examinations at Lyndon B. Johnson General Hospital in Texas
- Patients whose access point is the antecubital fossa
- Patients receiving 20 or 22 gauge catheters for their CT exam
- Patients scanned on two 64 slice CT scanners at the same hospital
Exclusion Criteria:
- patients whose access point is other than antecubital fossa
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Becton Dickinson Nexiva Diffusics System
Intervention with the new Becton Dickinson Nexiva Diffusics System will be evaluated to see if it will improve image quality compared to the standard catheter.
|
Becton Dickinson Nexiva Diffusics System will be used to inject IV contrast and will be compared to a single hole catheter to see if it improves image quality in the main vessels in the abdomen and pelvis because of its novel design.
|
|
Active Comparator: Standard intravenous catheter
Standard catheter with one hole at the tip will be compared to novel 3 hole Becton Dickinson Nexiva Diffusics System to see which catheter provides the best image quality.
|
Standard catheter with one hole at the tip will be compared to a novel 3 hole catheter to see which catheter provides the best image quality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Image Quality as Assessed by Ratio of Tissue Density of Main Portal Vein (MPV) to the Aorta
Time Frame: at the time of CT scanning
|
The ratio of tissue density measured in the main portal vein (MPV) to tissue density in the aorta on the CT images will be determined and will provide a measure of biodistribution, which is an important indicator of image quality.
Dividing each Hounsfield unit measurement by the aorta density and determining these ratios will be done on a per patient basis to assess biodistribution as a measure of image quality.
|
at the time of CT scanning
|
|
Image Quality as Assessed by Ratio of Tissue Density of Spleen to the Aorta
Time Frame: at the time of CT scanning
|
The ratio of tissue density measured in the spleen to tissue density in the aorta on the CT images will be determined and will provide a measure of biodistribution, which is an important indicator of image quality.
Dividing each Hounsfield unit measurement by the aorta density and determining these ratios will be done on a per patient basis to assess biodistribution as a measure of image quality.
|
at the time of CT scanning
|
|
Image Quality as Assessed by Ratio of Tissue Density of Inferior Vena Cava (IVC) to the Aorta
Time Frame: at the time of CT scanning
|
The ratio of tissue density measured in the inferior vena cava (IVC) to tissue density in the aorta on the CT images will be determined and will provide a measure of biodistribution, which is an important indicator of image quality.
Dividing each Hounsfield unit measurement by the aorta density and determining these ratios will be done on a per patient basis to assess biodistribution as a measure of image quality.
|
at the time of CT scanning
|
|
Image Quality as Assessed by Rating Scale
Time Frame: at the time of CT scanning
|
Radiologists blinded to catheter type will review images and rate them on a scale of 1 to 10. 10 indicates a better outcome.
|
at the time of CT scanning
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Contrast Infusion Pressure
Time Frame: at the time of CT scanning
|
The peak contrast infusion pressure is recorded in the electronic health record (EHR) during every CT examination preformed at the hospitals taking part in this study.
|
at the time of CT scanning
|
|
Injection Flow Rate
Time Frame: at the time of CT scanning
|
The injection flow rate is recorded in the electronic health record (EHR) during every CT examination preformed at the hospitals taking part in this study.
|
at the time of CT scanning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joseph Hasapes, MD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2016
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
November 1, 2016
Study Registration Dates
First Submitted
October 20, 2016
First Submitted That Met QC Criteria
October 20, 2016
First Posted (Estimate)
October 24, 2016
Study Record Updates
Last Update Posted (Actual)
June 6, 2018
Last Update Submitted That Met QC Criteria
May 3, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- HSC-MS15-0906
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contrast Enhanced Computed Tomography (CT) Scanning
-
Becton, Dickinson and CompanyCompletedContrast Enhanced Computed TomographyUnited States
-
Bracco Diagnostics, IncCompletedPatients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any Diagnostic CauseUnited States, Italy
-
University of Wisconsin, MadisonRecruiting
-
Karolinska University HospitalRecruitingCardiac Output | Contrast Media | Coronary Computed Tomography AngiographySweden
-
Vidacare CorporationTerminatedPatients With Intraosseous Vascular Access Requiring Computed Tomography (CT) ExamUnited States
-
Hartford HospitalUnknownRoutine Outpatients Undergoing Contrast Enhanced CT Scan of the Abdomen and PelvisUnited States
-
Paul Peng, MD PhD MSCRNot yet recruitingComputed Tomography | Hypersensitivity Reaction | Premedication | Allergic Reaction to Contrast Media
-
Cairo UniversityCompletedShort-Term Renal-Hematologic Safety | Contrast-Enhanced MRI and FDG-PET/CT | Spinal PathologyEgypt
-
The Second Hospital of Shandong UniversityCompletedSegmentectomy | Video- Assisted Thoracoscopic Surgery | Three-dimensional-computed Tomography (3D-CT) | Thin Cross- Section of CTChina
-
University Hospital, Basel, SwitzerlandCompletedKidney Neoplasms | Ultrasonography | Computed Tomography | Contrast MediaSwitzerland
Clinical Trials on Becton Dickinson Nexiva Diffusics System
-
University of Texas Southwestern Medical CenterBecton, Dickinson and CompanyCompleted
-
Becton, Dickinson and CompanyCompletedContrast Enhanced Computed TomographyUnited States
-
University of BialystokUnknown
-
Oregon Health and Science UniversityRecruiting
-
Gülçin Özalp GerçekerCompletedCatheter Complications | Catheter LeakageTurkey
-
Hospital San Carlos, MadridFoundation for Biomedical Research and InnovationCompletedCatheterization, PeripheralSpain
-
University of Lausanne HospitalsCompletedIntradermal (ID) Vaccination Device
-
Poitiers University HospitalCompletedIntravascular-catheter Colonization | Catheter FailureFrance